Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug Safety and Relevant Issues in the Real-World.
Barbieri MA, Irrera N, Convertino I. Barbieri MA, et al. Among authors: convertino i. Pharmaceuticals (Basel). 2023 Dec 5;16(12):1689. doi: 10.3390/ph16121689. Pharmaceuticals (Basel). 2023. PMID: 38139815 Free PMC article.
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Convertino I, Cazzato M, Tillati S, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Bonaso M, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Front Pharmacol. 2023 Sep 25;14:1244486. doi: 10.3389/fphar.2023.1244486. eCollection 2023. Front Pharmacol. 2023. PMID: 37818193 Free PMC article.
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use.
Ferraro S, Cappello E, Bartolini C, Convertino I, Bertani L, Lucenteforte E, Costa F, Paoletti O, Giometto S, Gini R, Tuccori M. Ferraro S, et al. Among authors: convertino i. Eur J Gastroenterol Hepatol. 2023 Nov 1;35(11):1263-1269. doi: 10.1097/MEG.0000000000002642. Epub 2023 Sep 18. Eur J Gastroenterol Hepatol. 2023. PMID: 37724478
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison.
Machado FLDS, Cañás M, Doubova SV, Urtasun MA, Marín GH, Osorio-de-Castro CGS, Albuquerque FC, Ribeiro TB, Pont L, Crisóstomo Landeros J, Roldán Saelzer J, Sepúlveda Viveros D, Acosta A, Machado Beltrán MA, Gordillo Alas LI, Orellana Tablas LA, Benko R, Convertino I, Bonaso M, Tuccori M, Kirchmayer U, Contreras Sánchez SE, Rodríguez-Tanta LY, Gutierrez Aures Y, Lin B, Alipour-Haris G, Eworuke E, Lopes LC. Machado FLDS, et al. Among authors: convertino i. Regul Toxicol Pharmacol. 2023 Oct;144:105485. doi: 10.1016/j.yrtph.2023.105485. Epub 2023 Sep 1. Regul Toxicol Pharmacol. 2023. PMID: 37659711
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Convertino I, Lorenzoni V, Gini R, Turchetti G, Fini E, Giometto S, Bartolini C, Paoletti O, Ferraro S, Cappello E, Valdiserra G, Bonaso M, Blandizzi C, Tuccori M, Lucenteforte E. Convertino I, et al. Pharmaceuticals (Basel). 2023 Mar 21;16(3):465. doi: 10.3390/ph16030465. Pharmaceuticals (Basel). 2023. PMID: 36986565 Free PMC article.
31 results